BPC-157, TB-500, and GHK-Cu are often discussed together in regenerative, tissue-model, and copper peptide research contexts. Search behavior sometimes groups them under phrases like "healing stack" or "Glow stack COA," but a research supplier should not treat those marketing labels as scientific documentation. For procurement and reproducibility, each peptide must be reviewed by exact identity, sequence, molecular weight basis, HPLC purity, mass spectrometry confirmation, and batch traceability.
This guide explains how to review BPC-157 COA, TB-500 specifications, and GHK-Cu purity research records without drifting into consumer-use claims. It is intended for researchers and lab buyers who need documentation quality, not dosing, administration, medical guidance, or outcome promises. Vespera products are strictly for research purposes only.
The key principle is simple: popular peptide clusters should not be purchased on popularity. They should be evaluated through traceable COAs and specification records.
Individual Peptide Profiles
The identity section is where many weak supplier pages create confusion. A product name is not enough. A research peptide documentation record should specify the exact molecule being sold.
BPC-157: Sequence, Molecular Weight, and Research Context
BPC-157 is commonly listed as a 15-amino-acid peptide with the sequence Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val, abbreviated GEPPPGKPADDAGLV. Public chemical references commonly list a molecular weight around 1419.5 Da for the free peptide.
For BPC-157 research peptide documentation, verify:
- Sequence: GEPPPGKPADDAGLV.
- Theoretical molecular weight and salt form.
- Observed mass from MS or LC-MS.
- HPLC purity result and chromatogram.
- Lot or batch number.
- COA date and testing lab.
The COA should not rely only on a product name. BPC-157 is frequently marketed in inconsistent ways, and the only useful procurement record is one that ties the exact sequence and batch to analytical data.
View Vespera BPC-157 research peptide or request available COA/spec documentation.
TB-500: Sequence, Molecular Weight, and Naming Caution
TB-500 documentation requires extra attention because naming varies across supplier catalogs. Some catalogs use TB-500 to refer to the short N-acetylated thymosin beta-4 fragment commonly written Ac-LKKTETQ. Other suppliers use TB-500 or "Thymosin Beta-4" to refer to the full-length 43-amino-acid thymosin beta-4 sequence. These are not the same analytical identity.
For that reason, a TB-500 COA should state exactly what was tested:
- Product name and synonym.
- Full sequence or fragment notation.
- Whether the material is a short fragment or full-length thymosin beta-4.
- Theoretical molecular weight for that exact identity.
- Observed mass by MS or LC-MS.
- HPLC purity result.
- Lot or batch number.
If a supplier shows a molecular weight near the short fragment range while the product is described as full-length thymosin beta-4, or vice versa, request clarification before accepting the record.
View Vespera TB-500 / Thymosin Beta-4 research peptide or request available COA/spec documentation.
GHK-Cu: Copper Peptide Identity and Molecular Weight Caveats
GHK-Cu refers to a copper complex of the tripeptide Gly-His-Lys. The underlying peptide sequence is GHK, but the copper complex, protonation state, counterions, and salt form affect how molecular weight and formula may be reported. Public chemical references commonly place copper tripeptide values around the low 400 Da range depending on the represented ion or salt.
For GHK-Cu purity research documentation, verify:
- Whether the document identifies GHK-Cu as a copper complex, not only the free GHK peptide.
- Formula and molecular weight basis.
- Copper content or complex identity when reported.
- HPLC or related purity method.
- MS identity data when suitable for the method.
- Lot number and COA date.
GHK-Cu is a useful example of why a headline purity percentage is not enough. The identity question includes the peptide and the metal complex. A specification sheet should make that distinction clear.
View Vespera GHK-Cu research peptide or request available COA/spec documentation.
Comparison Table: Applications, Stability, and Research Pairings
This table is framed for research taxonomy and procurement review. It is not a protocol or use guide.
| Peptide | Identity point | Common research context language | Documentation concern | Batch review priority |
|---|---|---|---|---|
| BPC-157 | 15-aa peptide, GEPPPGKPADDAGLV | Tissue-model, cytoprotective, pathway research references | Confirm sequence and salt form | HPLC purity plus MS identity |
| TB-500 | Naming may mean fragment or full-length thymosin beta-4 | Thymosin beta-4 and actin-related research references | Confirm exact sequence and MW | Resolve fragment vs full-length identity |
| GHK-Cu | Copper complex of Gly-His-Lys | Copper peptide and matrix-model research references | Confirm complex, not only free GHK | Identity, copper complex notation, purity |
Common Research Pairing Language
Supplier pages often use cluster language because buyers search for related peptides together. That can be acceptable for navigation, but it should not replace component-level documentation. If a product page or bundle mentions BPC-157, TB-500, and GHK-Cu together, each component should still have its own identity and batch record.
For blend terminology, including phrases like Glow stack COA, researchers should verify:
- Whether the product is actually a blend or simply a category grouping.
- Whether each component has a separate COA.
- Whether the blend has its own batch record.
- Whether the COA reports component identity and ratios, if applicable.
- Whether the supplier avoids medical or cosmetic claims.
COA and Documentation Deep Dive
A strong COA for these peptides should cover identity, purity, and traceability. Because each peptide has different identity risks, the review emphasis changes slightly.
BPC-157 COA Review
For BPC-157, start by confirming the 15-amino-acid sequence. Then review HPLC purity and mass spectrometry.
| BPC-157 field | Strong record | Weak record |
|---|---|---|
| Sequence | GEPPPGKPADDAGLV listed | Sequence missing |
| Molecular weight | Theoretical MW listed with basis | Only product name shown |
| HPLC | Purity result plus chromatogram | "99% pure" text only |
| MS | Observed mass matches expected identity | No MS data |
| Batch | Lot number on COA and vial | No traceable lot |
TB-500 Specifications Review
TB-500 requires a nomenclature check before purity review. A high purity value for the wrong identity is still the wrong product record.
Questions to ask:
- Does the COA identify the product as TB-500, thymosin beta-4, or a fragment?
- Is the sequence shown?
- Does the molecular weight align with the stated identity?
- Is the MS result consistent with the stated sequence?
- Does the vial label use the same product name as the COA?
If any of these answers are unclear, ask the supplier for a corrected specification sheet.
GHK-Cu Purity Review
For GHK-Cu, the main issue is whether the document confirms the copper complex and not just the tripeptide. Depending on method, HPLC may be used for peptide-related purity, while additional assays may be needed to characterize copper content or complexation. The COA should make clear what each test does and does not measure.
Recommended fields:
- Product name: GHK-Cu or copper tripeptide.
- Sequence: GHK.
- Formula or molecular weight basis.
- Copper complex notation.
- HPLC or UPLC purity result.
- MS or identity confirmation when applicable.
- Lot number and document date.
Purity Expectations and Analytical Tests
For research peptide suppliers, 98%+ HPLC purity is a common specification claim. Some suppliers target >=99%. The threshold matters less than whether the supplier provides real batch data.
HPLC or UPLC Purity
HPLC separates sample components and estimates purity based on peak area under the stated method. UPLC is a related high-efficiency chromatographic approach. In both cases, a result should be read with:
- Method label.
- Chromatogram.
- Acceptance criterion.
- Main peak retention time.
- Integration notes when available.
Mass Spectrometry Identity
MS or LC-MS should compare observed mass to theoretical mass. For BPC-157 and TB-500, this is especially important because sequence identity is central. For GHK-Cu, identity interpretation may require more context because metal complexes and ions can be reported differently.
Net Peptide Content
Net peptide content is distinct from chromatographic purity. It can be important for quantitative research records because lyophilized material can include salts, water, and counterions. If exact content matters, request the supplier's net peptide content or assay method.
Residual Solvents and Counterions
Peptide synthesis and purification can leave residual solvents or counterions. A specification sheet may list acetate, TFA, HCl, or other forms. Do not assume all versions of the same peptide are analytically identical.
Red Flags and Verification Checklist
Red Flags
| Red flag | Why it matters |
|---|---|
| BPC-157 COA lacks sequence | The identity cannot be reviewed |
| TB-500 COA omits fragment vs full-length status | The product identity may be ambiguous |
| GHK-Cu COA does not mention copper complex | The document may describe only GHK |
| Same chromatogram appears across multiple products | Possible recycled documentation |
| No lot number | Cannot match COA to vial |
| No mass spec data | Identity confirmation is incomplete |
| Medical, healing, cosmetic, or recovery claims | Research supplier copy should remain documentation-focused |
| Purity claim without chromatogram | The number is not independently reviewable |
Verification Checklist
- Confirm the product page name and vial label match.
- Confirm the SKU and strength match the order.
- Confirm the lot number on the COA matches the vial or packing slip.
- Confirm the sequence or exact identity is listed.
- Confirm HPLC or UPLC purity is shown with an acceptance criterion.
- Confirm MS identity data is included or available.
- Confirm molecular weight aligns with the exact identity and salt form.
- Confirm the document date is reasonable for the batch.
- Save the COA with the invoice and receiving record.
- Reject or escalate records with unsupported claims or mismatched identity fields.
Practical Review Workflow for a Receiving Team
For a research buyer, the review should be repeatable. The same workflow can be used whether the material is one BPC-157 vial, a TB-500 order, a GHK-Cu order, or a grouped purchase containing all three.
Step 1: Build the Product Record
Start with the supplier-facing record. Save the product page or catalog entry showing the name, SKU, listed format, and research-use-only language. If the product page uses a broad phrase such as "regenerative research peptide," do not treat that phrase as the identity. Identity comes from sequence, formula, and analytical documentation.
Step 2: Match the Received Item
When the material arrives, compare the vial label with the order record. Record product name, SKU, lot number, quantity or vial size, and any storage label. This receiving check is basic, but it prevents a common documentation failure: saving a COA that belongs to a different SKU or a different lot.
Step 3: Review Identity Before Purity
Purity is only meaningful after identity is clear. For BPC-157, confirm the 15-amino-acid sequence. For TB-500, resolve whether the product is the short fragment or full-length thymosin beta-4. For GHK-Cu, confirm that the copper complex is documented. Only then should the HPLC purity number be accepted as relevant to the product.
Step 4: Review Analytical Data
Read HPLC and MS together. HPLC estimates chromatographic purity under the listed method; MS helps confirm that the dominant material matches the expected mass. If a supplier provides only HPLC, request MS. If a supplier provides only MS, request purity data. A credible research supplier should understand why both questions matter.
Step 5: Archive the Record
Save the COA, product page, invoice, packing slip, and label photo in the same internal folder. Name the file with product and lot number, such as BPC-157_VP-BPC-5_Lot-XXXX_COA.pdf. Clear file naming makes later vendor review easier and reduces the chance of mixing records between product clusters.
Downloadable Checklist Suggestion
Suggested PDF: BPC-157, TB-500 and GHK-Cu COA Review Checklist.
Include one page with three columns:
| Field | BPC-157 | TB-500 | GHK-Cu |
|---|---|---|---|
| Sequence confirmed | |||
| Lot number matches vial | |||
| HPLC purity reviewed | |||
| MS identity reviewed | |||
| MW basis understood | |||
| Salt/complex form reviewed | |||
| COA date recorded |
CTA: Download the BPC/TB/GHK COA checklist.
Vespera Trust Section: Product and COA Links
Vespera product pages are organized for research procurement and documentation requests.
- BPC-157 research peptide
- TB-500 / Thymosin Beta-4 research peptide
- GHK-Cu research peptide
- Cytoprotective and regenerative research category
- Request available COA/spec documentation
When requesting documentation, include the product name, SKU, order number or purchase email, and lot number if available. For TB-500, include any question about fragment vs full-length identity directly in the notes field.
Supplier Questions That Keep the Review Documentation-Focused
The best supplier questions are precise and avoid use claims. Use language like this:
- Can you confirm whether this TB-500 lot is a short fragment or full-length thymosin beta-4?
- Can you provide the HPLC chromatogram for this BPC-157 batch?
- Does the GHK-Cu specification sheet identify copper complexation or only the GHK peptide?
- Is the molecular weight listed for the free peptide, salt form, or observed MS ion?
- Does the COA match the lot number printed on the vial?
- Was the analysis performed in-house, by a third-party lab, or both?
Avoid asking suppliers for protocol, administration, or outcome guidance. A transparent supplier should answer documentation questions clearly and keep the conversation within research-use-only boundaries.
Analytical Reference Notes
General analytical chemistry principles support this review process. HPLC and UPLC are separation methods used to estimate chromatographic purity. Mass spectrometry supports identity by comparing observed mass signals with theoretical mass. Public records such as PubChem BPC-157, PubChem thymosin beta-4, and PubChem copper tripeptide can help reviewers understand formula and mass context, but batch-specific supplier records still control procurement review. ICH Q2(R2) provides a widely recognized framework for analytical procedure validation concepts such as specificity, accuracy, precision, and range. FDA bioanalytical method validation guidance discusses chromatographic and mass spectrometric documentation in regulated settings. Research peptide COAs are supplier records, not regulatory approvals, but transparent methods and traceable results remain the standard for credible documentation.
Conclusion
BPC-157, TB-500, and GHK-Cu are high-interest research peptides, but high interest does not reduce the need for documentation. A supplier should be able to show what the product is, which batch was tested, how purity was measured, and how identity was confirmed.
For BPC-157, sequence confirmation is central. For TB-500, exact naming and molecular weight are critical because fragment and full-length terminology can be confused. For GHK-Cu, the copper complex must be documented clearly. Across all three, batch-matched COAs are the trust signal.
Browse Vespera research peptides or request available documentation: BPC-157, TB-500, GHK-Cu, and COA / Specs Request.
FAQ
What should a BPC-157 COA show?
A BPC-157 COA should show product name, sequence, lot number, HPLC purity, mass spectrometry identity data, theoretical and observed molecular weight, test date, and lab or supplier document details.
What are TB-500 specifications?
TB-500 specifications should identify whether the product is a short thymosin beta-4 fragment or full-length thymosin beta-4, then list sequence, molecular weight basis, purity method, identity method, and batch information.
Why is TB-500 naming a red flag?
Supplier catalogs use TB-500 terminology inconsistently. Some mean a short fragment, while others mean full-length thymosin beta-4. The COA must specify the exact tested identity.
What should a GHK-Cu COA include?
A GHK-Cu COA should identify the product as a copper complex of GHK, list formula or molecular weight basis, report purity or assay results, and provide lot-level traceability.
Is 98% HPLC purity enough?
No. A 98%+ HPLC result is useful, but it should be paired with identity confirmation by MS or another suitable method and should match the exact batch.
How do I review a Glow stack COA?
First determine whether the product is a true blend or a marketing bundle. Each component should be identifiable, batch traceable, and supported by COA/spec documentation. Avoid records that hide component identity behind blend language.
Does this article discuss healing or recovery use?
No. This article is strictly for research procurement and analytical documentation review. It does not provide medical advice, dosing, administration instructions, or consumer-use claims.
How can I request Vespera COAs?
Use the COA / Specs Request page and include product name, SKU, order details, and lot number if available.